{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-084645","form_type":"8-K","ticker":"SGMT","cik":"0001400118","company_name":"Sagimet Biosciences Inc.","filed_at":"2024-08-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.914162+00:00","generated_at":"2026-05-31T13:43:54.871216+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Sagimet Biosciences expands board to 9, appoints Jennifer Jarrett and Dr. Anne Phillips as directors","bullets":["Board expanded from 7 to 9 directors; appointments effective August 1, 2024.","Jennifer Jarrett, COO of Arcus Biosciences, joins Audit Committee; Dr. Anne Phillips, former Novo Nordisk SVP, joins Nominating & Governance Committee.","Each new director receives initial stock option grant of $300,000 vesting over 3 years under 2023 Stock Option Plan.","Both are independent under Nasdaq rules; no related party transactions disclosed.","Jarrett serves on boards of Syndax, Zura Bio, others; Phillips on boards of Trevena, Barinthus, vTv Therapeutics."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-084645","json":"https://secwatch.observer/filing/0001104659-24-084645.json","markdown":"https://secwatch.observer/filing/0001104659-24-084645.md","text":"https://secwatch.observer/filing/0001104659-24-084645.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1400118/000110465924084645/0001104659-24-084645-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1400118/000110465924084645/tm2420572d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T13:43:54.871216+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"42aeb14fc5","claim":"Dr. Anne Phillips was appointed as Director at Sagimet Biosciences Inc..","evidence_excerpt":"the board of directors (the “Board”) of Sagimet Biosciences Inc. (the “Company”) approved the expansion of the Board from seven directors to nine directors and the appointment of each of Jennifer Jarrett and Dr. Anne Phillips to serve as directors of the Board, in each case, effective as of August 1, 2024","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1400118/000110465924084645/0001104659-24-084645-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"91b06036d4","claim":"Jennifer Jarrett was appointed as Director at Sagimet Biosciences Inc..","evidence_excerpt":"the board of directors (the “Board”) of Sagimet Biosciences Inc. (the “Company”) approved the expansion of the Board from seven directors to nine directors and the appointment of each of Jennifer Jarrett and Dr. Anne Phillips to serve as directors of the Board, in each case, effective as of August 1, 2024","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1400118/000110465924084645/0001104659-24-084645-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}